Modulation of murine phenobarbital-inducible CYP2A5, CYP2B10 and CYP1A enzymes by inhibitors of protein kinases and phosphatases

European Journal of Biochemistry

Volumn 264, Issue 1, 1999, Pages 19-26

  Posti, Katja ^a   Leinonen, Susanna ^a   Tetri, Sami ^a   Kottari, Sami ^a   Viitala, Pirkko ^a   Pelkonen, Olavi ^a   Raunio, Hannu ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

CYP induction; Phosphorylation; Primary hepatocytes

Indexed keywords

2 AMINOPURINE; CALYCULIN A; COUMARIN; CYTOCHROME; ETHOXYRESORUFIN DEETHYLASE; OKADAIC ACID; PHENOBARBITAL; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE INHIBITOR; TAUTOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CATALYSIS; CELL CYCLE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INDUCTION; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; CATALYSIS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; ENZYME INHIBITORS; ISOENZYMES; LIVER; MALE; MICE; MICE, INBRED DBA; PHENOBARBITAL; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE INHIBITORS;

ANIMALIA; MURINAE;

EID: 0033567282     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00539.x     Document Type: Article

References (54)

1. 1. Whysner, J., Ross, P.M. & Williams, G.M. (1996) Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol. Ther. 71, 153-191.
2. 2. Frueh, F.W., Zanger, U.M. & Meyer, U.A. (1997) Extent and character of phenobarbital-mediated changes in gene expression in the liver. Mol. Pharmacol. 51, 363-369.
3. 3. Nelson, D.R., Koymans, L., Kamataki, T., Stegeman, J.J., Feyereisen, R., Waxman, D.J., Waterman, M.R., Gotoh, O., Coon, M.J., Estabrook, R.W., Gunsalus, I.C. & Nebert, D.W. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42.
4. 4. Waxman, D.J. & Azaroff, L. (1992) Phenobarbital induction of cylochrome P-450 gene expression. Biochem. J. 281, 577-592.
5. 5. Chang, T.K.H. & Waxman, D.J. (1996) The CYP2A subfamily. In Cytochromes P450. Metabolic and Toxicological Aspects (Ioannides, C., ed.), pp. 99-134. CRC Press, Boca Raton, FL.
6. 6. Pelkonen, O., Raunio, H., Rautio, A., Mäenpää, J. & Lang, M.A. (1993) Coumarin 7-hydroxylase: characteristics and regulation in mouse and man. J. Irish Coll. Phys. Surg. 22, 24-28.
7. 7. Pelkonen, O. & Raunio, H. (1995) Individual expression of carcinogen-metabolizing enzymes: cytochrome P4502A. J. Occup. Environ. Med. 37, 19-24.
8. 8. Kirby, G.M., Chemin, I., Montesano, R., Chisari, F.V., Lang, M.A. & Wild, C.P. (1994) Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Mol. Carcinog. 11, 74-80.
9. 9. Chemin, I., Takahashi, S., Belloc, C., Lang, M.A., Ando, K., Guidotti, L.G., Chisari, F.V. & Wild, C.P. (1996) Differential induction of carcinogen metabolizing enzymes in a transgenic mouse model of fulminant hepatitis. Hepatology 24, 649-656.
10. 10. Salonpää, P., Iscan, M., Pasanen, M., Arvela, P., Pelkonen, O. & Raunio, H. (1992) Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice. Biochem. Pharmacol. 44, 1269-1274.
11. 11. Pellinen, P., Stenbäck, F., Rautio, A., Pelkonen, O., Lang, M.A. & Pasanen, M. (1993) Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases. Naunyn-Schmiedeberg Arch. Pharmacol. 348, 435-443.
12. 12. Pellinen, P., Stenbäck, F., Kojo, A., Honkakoski, P., Gelboin, H.V. & Pasanen, M. (1996) Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine. Hepatology 23, 515-523.
13. 13. Camus-Randon, A.-M., Raffalli, F., Bereziat, J.-C., McGregor, D., Konstandi, M. & Lang, M.A. (1996) Liver injury and expression of cytochrome P450: evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes. Toxicol. Appl. Pharmacol. 138, 140-148.
14. 14. Lange, R., Perin, F., Larroque, C. & Zajdela, F. (1990) Isolation and partial characterization of a cytochrome P-450 isozymes (cytochrome P-450tu) from mouse liver tumors. Biochim. Biophys. Acta 1038, 130-135.
15. 15. Kobliakov, V., Kulikova, L., Samoilov, D. & Lang, M.A. (1993) High expression of cytochrome P450, 2a-5 (coumarin 7-hydroxylase) in mouse hepatomas. Mol. Carcinog. 7, 276-280.
16. 16. Kirby, G.M., Batist, G., Alpert, L., Lamoureux, E., Cameron, R.G. & Alaoui-Jamali, M.A. (1996) Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis. Toxicol. Pathol. 24, 458-467.
17. 17. Raunio, H., Juvonen, R., Pasanen, M., Pelkonen, O., Pääkkö, P. & Soini, Y. (1998) Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma. Hepatology 27, 427-432.
18. 18. Salonpää, P., Pelkonen, O., Kojo, A., Pasanen, M., Negishi, M. & Raunio, H. (1994) CYP2A5 expression and inducibility by phenobarbital is modulated by cAMP in mouse primary hepatocytes. Biochem. Biophys. Res. Commun. 205, 631 -637.
19. 19. Salonpää, R, Kottari, S., Pelkonen, O. & Raunio, H. (1997) Regulation of CYP2A5 induction by porphyrinogenic agents in mouse primary hepatocytes. Naunyn-Schmiedeberg Arch. Pharmacol 355, 8-13.
20. 20. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Cell 72, 248-254.
21. 21. Aitio, A. (1978) A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal. Biochem. 85, 488-491.
22. 22. Burke, M.D., Prough, R.A. & Mayer, R.T. (1977) Characteristics of a microsomal cytochrome P-448-mediated reaction: ethoxyresorufin O-deethylation. Drug Metab. Dispos. 5, 1-8.
23. 23. Negishi, M., Lindberg, R., Burkhart, B., Ichikawa, T., Honkakoski, P. & Lang, M. (1989) Mouse steroid 15α-hydroxylase gene family: identification of type II P-45015a as coumarin 7-hydroxylase. Biochemistry 28, 4169-4172.
24. 24. Honkakoski, P., Kojo, A. & Lang, M.A. (1992) Regulation of mouse liver P450, 2B subfamily by sex hormones and phenobarbital. Biochem. J. 285, 979-983.
25. 25. Andreassen, P.R. & Margolis, R.L. (1992) 2-Aminopurine overrides multiple cell cycle checkpoints in BHK cells. Proc. Natl Acad. Sci. USA 89, 2272-2276.
26. 26. Andreassen, P.R. & Margolis, R.L. (1994) Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J. Cell Biol. 127, 789-802.
27. 27. Mahadevan, L.C., Wills, A.J., Hirst, E.A., Rathjen, P.D. & Heath, J.K. (1990) 2-Aminopurine abolishes EGF-and TPA-stimulated pp.33 phosphorylation and c-fos induction without affecting the activation of protein kinase C. Oncogene 5, 327-335.
28. 28. Maio, J.J., Graham, G.J. & Brown, F.L. (1995) Induction of G2 arrest and gene expression by 2-aminopurine in human U937 promonocyte-macrophage cells. J. Biol. Chem. 246, 5199-5206.
29. 29. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Mullauer, L., Taper, H., Huber, W., Bursch, W. & Schulte-Hermann, R. (1997) Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25, 906-912.
30. 30. Bursch, W., Lauer, B., Timmermann-Trosiener, I., Barthel, G., Schuppler, J. & Schulte-Hermann, R. (1984) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5, 453-458.
31. 31. Waskiewicz, A.J. & Cooper, J.A. (1995) Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol 7, 798-805.
32. 32. De Benedetti, A. & Baglioni, C. (1983) Phosphorylation of initiation factor eIF-2α, binding of mRNA to 48S complexes, and its reutilization in initiation of protein synthesis. J. Biol. Chem. 258, 14556-14562.
33. 33. Thorburn, J., Frost, J.A. & Thorbum, A. (1994) Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J. Cell Biol. 126, 1565-1572.
34. 34. Nirodi, C.S., Sultana, S., Ram, N., Prabhu, L. & Padmanaban, G. (1996) Involvement of synthesis and phosphorylation of nuclear protein factors that bind to the positive cis-acting element in the transcriptional activation of the CYP2B1/B2 gene by phenobarbitone in vivo. Arch. Biochem. Biophys. 331, 79-86.
35. 35. Dogra, S.C. & May, B.K. (1996) Phenobarbital-induced activation of CYP2H1 and 5-aminolevulinate synthase genes in chick embryo hepatocytes is blocked by an inhibitor of protein phosphorylation. Arch. Biochem. Biophys. 327, 271-278.
36. 36. Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J. & Saltiel, A.R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl Acad. Sci. USA 92, 7686-7689.
37. 37. Hunter, T. (1995) Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell 80, 225-236.
38. 38. Sidhu, J.S. & Omiecinski, C.J. (1997) An okadaic acid-sensitive pathway involved in the phenobarbital-mediated induction of CYP2B gene expression in primary rat hepatocyte cultures. J. Pharmacol. Exp. Ther. 282, 1122-1129.
39. 39. Honkakoski, P. & Negishi, M. (1998) Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. Biochem. J. 330, 889-895.
40. 40. Oesch-Bartlomowicz, B., Arens, H.J., Richter, B., Henstler, J.G. & Oesch, F. (1999) Control of the mutagenicity of aromatic amines by protein kinases and phosphatases I. The protein phosphatase inhibitors okadaic acid and ortho-vanadate drastically reduce the mutagenicity of aromatic amines. Arch. Toxicol. 71, 601-611.
41. 41. Tohkin, M., Kurose, K. & Fukuhara, M. (1996) Okadaic acid potentiates 3-methylcholanthrene-induced CYP2A8 gene expression in primary cultures of Syrian hamster hepatocytes: possible involvement of activator protein-1. Mol. Pharmacol. 50, 556-564.
42. 42. Raunio, H., Syngelmä, T., Pasanen, M., Juvonen, R., Honkakoski, P., Kairaluoma, M.A., Sotaníemi, E.A., Lang, M.A. & Pelkonen, O. (1988) Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochem. Pharmacol. 37, 3889-3895.
43. 43. Honkakoski, P., Moore, R., Gynther, J. & Negishi, M. (1996) Characterization of phenobarbital-inducible mouse Cyp2b10 gene transcription in primary hepatocytes. J. Biol. Chem. 271, 9746-9753.
44. 44. Aida, K. & Negishi, M. (1991) Post-transcriptional regulation of coumarin 7-hydroxylase (P450Coh) induction by xenobiotics in mouse liver: mRNA stabilization by pyrazole. Biochemistry 30, 8041-8045.
45. 45. Geneste, O., Raffalli, F. & Lang, M.A. (1996) Identification and characterization of a 44 kDa protein that binds specifically to the 3′ untranslated region of CYP2a5 mRNA: inducibility, subcellular distribution and possible role in mRNA stabilization. Biochem. J. 313, 1029-1037.
46. 46. Hahnemann, B., Salonpää, P., Pasanen, M., Mäenpää, J., Honkakoski, P., Juvonen, R., Lang, M.A., Pelkonen, O. & Raunio, H. (1992) Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450, 2a-4/5 (Cyp2a-4/5) expression. Biochem. J. 286, 289-294.
47. 47. Baffet, G. & Corcos, L. (1995) The liver-specific response to phenobarbital involves a transient increase in phosphorylation of a 34-kDa nuclear protein in rat liver and in hepatocytes in culture. Biochem. Biophys. Res. Commun. 216, 947-956.
48. 48. Prabhu, L., Upadhya, P., Ram, N., Nirodi, C.S., Sultana, S., Vatsala, P.G., Mani, S.A., Rangarajan, P.N., Surolia, A. & Padmanaban, G. (1995) A model for the transcriptional regulation of the CYP2B1/B2 gene in rat liver. Proc. Natl Acad. Sci. USA 92, 9628-9632.
49. 49. Sadar, M.D., Blomstrand, F. & Andersson, T.B. (1996) Phenobarbital induction of cytochrome P4501A1 is regulated by cAMP-dependent protein kinase-mediated signaling pathways in rainbow trout hepatocytes. Biochem. Biophys. Res. Commun. 225, 455-461.
50. 50. Honkakoski, P. & Negishi, M. (1997) Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene. J. Biol. Chem. 272, 14943-14949.
51. 51. Sadar, M.D., Ash, R., Sundqvist, J., Olsson, P.-E. & Andersson, T.B. (1996) Phenobarbital induction of Cyp1A1 gene expression in a primary culture of rainbow trout hepatocytes. J. Biol. Chem. 271, 17635-17643.
52. 52. Matsumura, F. (1994) How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals. Biochem. Pharmacol. 48, 215-224.
53. 53. Carrier, F., Owens, R.A., Nebert, D.W. & Puga, A. (1992) Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol. Cell. Biol. 12, 1856-1863.
54. 54. Guillouzo, A., Morel, F., Langouet, S., Maheo, K. & Rissel, M. (1997) Use of hepatocyte cultures for the study of hepatotoxic compounds. J. Hepatol. 26, 73-80.